FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer

od Liu, Cassie, Barger, Carter J., Karpf, Adam R.
Izdano u Cancers (Basel) (2021)

Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer

od Barger, Carter J, Branick, Connor, Chee, Linda, Karpf, Adam R.
Izdano u Cancers (Basel) (2019)

Protein Kinase Cα (PKCα) Is Resistant to Long Term Desensitization/Down-regulation by Prolonged Diacylglycerol Stimulation

od Lum, Michelle A., Barger, Carter J., Hsu, Alice H., Leontieva, Olga V., Black, Adrian R., Black, Jennifer D.
Izdano u J Biol Chem (2016)

DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer

od Zhang, Wa, Barger, Carter J, Link, Petra A, Mhawech-Fauceglia, Paulette, Miller, Austin, Akers, Stacey N, Odunsi, Kunle, Karpf, Adam R
Izdano u Epigenetics (2015)

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression

od Barger, Carter J., Zhang, Wa, Hillman, Joanna, Stablewski, Aimee B., Higgins, Michael J., Vanderhyden, Barbara C., Odunsi, Kunle, Karpf, Adam R.
Izdano u Oncotarget (2015)

Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability

od Zhang, Wa, Klinkebiel, David, Barger, Carter J., Pandey, Sanjit, Guda, Chittibabu, Miller, Austin, Akers, Stacey N., Odunsi, Kunle, Karpf, Adam R.
Izdano u Cancers (Basel) (2020)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer

od Zhang, Wa, Barger, Carter J., Eng, Kevin H., Klinkebiel, David, Link, Petra A., Omilian, Angela, Bshara, Wiam, Odunsi, Kunle, Karpf, Adam R.
Izdano u Oncotarget (2016)

NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma

od Haque, Moinul, Li, Jing, Huang, Yung-Hsing, Almowaled, Meaad, Barger, Carter J., Karpf, Adam R., Wang, Peng, Chen, Will, Turner, Suzanne D., Lai, Raymond
Izdano u Cancers (Basel) (2019)

Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer

od Barger, Carter J, Chee, Linda, Albahrani, Mustafa, Munoz-Trujillo, Catalina, Boghean, Lidia, Branick, Connor, Odunsi, Kunle, Drapkin, Ronny, Zou, Lee, Karpf, Adam R
Izdano u eLife (2021)

Expression of the POTE gene family in human ovarian cancer

od Barger, Carter J, Zhang, Wa, Sharma, Ashok, Chee, Linda, James, Smitha R., Kufel, Christina N., Miller, Austin, Meza, Jane, Drapkin, Ronny, Odunsi, Kunle, Klinkebiel, David, Karpf, Adam R.
Izdano u Sci Rep (2018)

CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax

od Kour, Smit, Rana, Sandeep, Contreras, Jacob I., King, Hannah M., Robb, Caroline M., Sonawane, Yogesh A., Bendjennat, Mourad, Crawford, Ayrianne J., Barger, Carter J., Kizhake, Smitha, Luo, Xu, Hollingsworth, Michael A., Natarajan, Amarnath
Izdano u Mol Pharmacol (2019)

BORIS expression in ovarian cancer precursor cells alters the CTCF cistrome and enhances invasiveness through GALNT14

od Hillman, Joanna C., Pugacheva, Elena M., Barger, Carter J., Sribenja, Sirinapa, Rosario, Spencer, Albahrani, Mustafa, Truskinovsky, Alexander M., Stablewski, Aimee, Liu, Song, Loukinov, Dmitri I., Zentner, Gabriel E., Lobanenkov, Victor V., Karpf, Adam R., Higgins, Michael J.
Izdano u Mol Cancer Res (2019)

Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

od Robb, Caroline M., Kour, Smit, Contreras, Jacob I., Agarwal, Ekta, Barger, Carter J., Rana, Sandeep, Sonawane, Yogesh, Neilsen, Beth K., Taylor, Margaret, Kizhake, Smitha, Thakare, Rhishikesh N., Chowdhury, Sanjib, Wang, Jing, Black, Jennifer D., Hollingsworth, Michael A., Brattain, Michael G., Natarajan, Amarnath
Izdano u Oncotarget (2017)

Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

od Robb, Caroline M., Kour, Smit, Contreras, Jacob I., Agarwal, Ekta, Barger, Carter J., Rana, Sandeep, Sonawane, Yogesh, Neilsen, Beth K., Taylor, Margaret, Kizhake, Smitha, Thakare, Rhishikesh N., Chowdhury, Sanjib, Wang, Jing, Black, Jennifer D., Hollingsworth, Michael A., Brattain, Michael G., Natarajan, Amarnath
Izdano u Oncotarget (2020)